ArticleThe oncologist2025

Pre-existing cardiovascular disease is associated with an increased risk of cardiovascular events during Bruton tyrosine kinase inhibitor therapy.

Maria J Fernandez Turizo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.